The hexosamine pathway is activated by high blood sugar levels, which causes damage to Schwann cells and nerve cells through inflammation and oxidative stress, eventually leading to diabetic peripheral neuropathy (DPN)
A common reconstitution creates approximately 3.33 mg/mL concentration
Standard dosing begins at 2.5 mg weekly, with escalation every four weeks up to 15 mg weekly based on clinical tolerance and therapeutic response
The hormone glucagon raises blood glucose levels by encouraging the liver to release glucose from glycogen
Qsymia Qysmia (phentermine and topiramate) is not a GLP-1 receptor agonist, but is a potential alternative to Ozempic for those struggling with weight, Adimoolam says
For assessment of the nuclear cytoplasmic ratio of Nrf2 signal intensity, the nucleus was defined by Hoechst H-33342 staining